After Hours Summary: HABT +10.5%, MRVL +2% following earnings/guidance.... IMMR -17%, NTNX -14%, BBG -9%, COST -4% lower following earnings/guidance, SCYX -28.7% on clinical trial delayAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: HABT +10.5%, SYN +2.5%, GWRE +2.4%, MRVL +2.1%
Companies trading higher in after hours in reaction to news: PPHM +10.8% (indicated higher after Ronin Capital discloses 6.8% active stake; may also wish to engage in a dialogue with officers, directors, and other representatives), BIOS +6.8% (enters into a Stock Purchase Agreement for the sale of an aggregate of 3,300,000 shares of its common stock for aggregate gross proceeds of $5,070,780 in a private placement), VTTI +3.5% (ticking higher; VTTI Energy Partners receives a proposal from VTTI B.V. pursuant to which VTTI would acquire through a wholly owned subsidiary all publicly held common units of the Partnership in exchange for $18.75/unit)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: IMMR -16.7%, NTNX -14.2%, BBG -9.4%, RGLS -9.1% (light volume), WING -6.9%, AOBC -5.1%, AMRS -4.5%, COST -4.1%, (Costco also confirmed plans for membership fee increase), ADSK -1.3%
Companies trading lower in after hours in reaction to news: SCYX -28.7% (delays the initiation of any new clinical studies with the IV formulation of SCY-078 until the FDA completes a review of all available pre-clinical and clinical data of the IV formulation of SCY-078), KPTI -15.1% (announced the results of a planned interim analysis of the Phase 2 SOPRA study evaluating single agent selinexor in relapsed/refractory acute myeloid leukemia; study will not reach statistically significant improvement in primary endpoint of overall survival in patients who are unfit for chemotherapy and/or transplantation), ZSAN -12.7% (files for $46 mln common stock offering), HMSY -8.8% (files to delay its 10-K; is continuing to evaluate whether this issue affects its consolidated financial results, primarily focusing on prior periods in which revenue relating to the CMS business was recorded), RGR -1.6% (AOBC sympathy), BLDR -1.5% (commences a secondary offering of 10,000,000 shares of its common stock to be sold by JLL Building Holdings)